Dataset Information


LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNF? expression and receptor tyrosine kinase signaling.

ABSTRACT: Smac mimetics block inhibitor of apoptosis proteins to trigger TNF?-dependent apoptosis in cancer cells. However, only a small subset of cancer cells seem to be sensitive to Smac mimetics and even sensitive cells can develop resistance. Herein, we elucidated mechanisms underlying the intrinsic and acquired resistance of cancer cells to Smac mimetics. In vitro and in vivo investigations revealed that the expression of the cell surface protein LRIG1, a negative regulator of receptor tyrosine kinases (RTK), is downregulated in resistant derivatives of breast cancer cells sensitive to Smac mimetics. RNA interference-mediated downregulation of LRIG1 markedly attenuated the growth inhibitory activity of the Smac mimetic SM-164 in drug-sensitive breast and ovarian cancer cells. Furthermore, LRIG1 downregulation attenuated TNF? gene expression induced by Smac mimetics and increased the activity of multiple RTKs, including c-Met and Ron. The multitargeted tyrosine kinase inhibitors Crizotinib and GSK1363089 greatly enhanced the anticancer activity of SM-164 in all resistant cell derivatives, with the combination of SM-164 and GSK1363089 also completely inhibiting the outgrowth of resistant tumors in vivo. Together, our findings show that both upregulation of RTK signaling and attenuated TNF? expression caused by LRIG1 downregulation confers resistance to Smac mimetics, with implications for a rational combination strategy.


PROVIDER: S-EPMC3294058 | BioStudies | 2012-01-01

REPOSITORIES: biostudies

Similar Datasets

2012-03-01 | E-GEOD-33827 | ArrayExpress
2011-01-01 | S-EPMC3091962 | BioStudies
2008-01-01 | S-EPMC2784911 | BioStudies
1000-01-01 | S-EPMC4229641 | BioStudies
2007-01-01 | S-EPMC2553712 | BioStudies
1000-01-01 | S-EPMC5085125 | BioStudies
1000-01-01 | S-EPMC4979953 | BioStudies
2021-11-18 | GSE140556 | GEO
1000-01-01 | S-EPMC5344208 | BioStudies
2009-01-01 | S-EPMC2697389 | BioStudies